Evidence map›Paper›PMID 21547719›Full record

ArticleJournal of neurodevelopmental disorders2009

Choline transporter gene variation is associated with attention-deficit hyperactivity disorder.

Brett A English, Maureen K Hahn, Ian R Gizer, Michelle Mazei-Robison, Angela Steele, Daniel M Kurnik, Mark A Stein, Irwin D Waldman, Randy D Blakely

Open access · hybridAbstract read
In one paragraph

Article in Journal of neurodevelopmental disorders, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. A Systematic Review and Meta-analysis of Chemical Exposures and Attention-Deficit/Hyperactivity Disorder in Children.Prevention science : the official journal of the Society for Prevention Research · 2024
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Disrupted Choline Clearance and Sustained Acetylcholine ReleaseThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  7. Review
  8. Attention-deficit/hyperactive disorder updates.Frontiers in molecular neuroscience · 2022
    Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. New Insights Into Cholinergic Neuron Diversity.Frontiers in molecular neuroscience · 2019
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Brett A EnglishDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, 37232-8548, USA.
Maureen K Hahn
Ian R Gizer
Michelle Mazei-Robison
Angela Steele
Daniel M Kurnik
Mark A Stein
Irwin D Waldman
Randy D Blakely
Vanderbilt University · USEmory University · USUniversity of Illinois Chicago · US

Funding

Structural genomics of norepinephrine transportersP01HL056693 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DIEDRICH, ANDRE · 1997 to 2016
$30.8M
Molecular Analysis of Presynaptic Choline TransportersR37MH073159 · NIMH · VANDERBILT UNIVERSITY · PI BLAKELY, RANDY D. · 2004 to 2013
$3.6M
MOLECULAR GENETICS OF CHILDHOOD DISRUPTIVE DISORDERSK01MH001818 · NIMH · EMORY UNIVERSITY · PI WALDMAN, IRWIN D · 2000 to 2004
$679k
Neurobehavioral Analysis of Norepinephrine Transporter VariantsK01MH076018 · NIMH · VANDERBILT UNIVERSITY · PI HAHN, MAUREEN K · 2006 to 2010
$655k
PRIMARY CARE--LAB FOR CLINICAL &BASIC RESEARCH ON ADHDK24MH001823 · NIMH · UNIVERSITY OF CHICAGO · PI STEIN, MARK A · 2000 to 2004
$543k
Endophenotypes for Molecular Genetic Studies of ADHDF31MH072083 · NIMH · EMORY UNIVERSITY · PI GIZER, IAN ROBERT · 2004 to 2006
$50k
NHLBI NIH HHS P01 HL056693NIMH NIH HHS F31 MH072083NIMH NIH HHS K01 MH001818NIMH NIH HHS K01 MH076018NIMH NIH HHS K24 MH001823NIMH NIH HHS R37 MH073159
6 · The paper itself

Abstract

The neurotransmitter acetylcholine (ACh) plays a critical role in brain circuits mediating motor control, attention, learning and memory. Cholinergic dysfunction is associated with multiple brain disorders including Alzheimer's Disease, addiction, schizophrenia and Attention-Deficit Hyperactivity Disorder (ADHD). The presynaptic choline transporter (CHT, SLC5A7) is the major, rate-limiting determinant of ACh production in the brain and periphery and is consequently upregulated during tasks that require sustained attention. Given the contribution of central cholinergic circuits to the control of movement and attention, we hypothesized that functional CHT gene variants might impact risk for ADHD. We performed a case-control study, followed by family-based association tests on a separate cohort, of two purportedly functional CHT polymorphisms (coding variant Ile89Val (rs1013940) and a genomic SNP 3' of the CHT gene (rs333229), affording both a replication sample and opportunities to reduce potential population stratification biases. Initial genotyping of pediatric ADHD subjects for two purportedly functional CHT alleles revealed a 2-3 fold elevation of the Val89 allele (n = 100; P = 0.02) relative to healthy controls, as well as a significant decrease of the 3'SNP minor allele in Caucasian male subjects (n = 60; P = 0.004). In family based association tests, we found significant overtransmission of the Val89 variant to children with a Combined subtype diagnosis (OR = 3.16; P = 0.01), with an increased Odds Ratio for a haplotype comprising both minor alleles. These studies show evidence of cholinergic deficits in ADHD, particularly for subjects with the Combined subtype, and, if replicated, may encourage further consideration of cholinergic agonist therapy in the disorder.

Identifiers

PMID21547719
PMCPMC3164006
OpenAlexW1976809862

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.